EMERALD ADVISERS, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001015083

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidDiversifiedHigh Turnover how tags are computed

Q2 2024 · 247 positions · Total reported value $2.38B · Top-10 concentration 21.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 51.0% · 14 new · 86 cut · 28 exited

Active Share (vs S&P 500): 97.9% · vs QQQ: 98.3% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -14.5% · vs SPY -16.6% · Prev Value $4.25B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -4.4% · vs SPY -6.6% · Latest Value $3.63B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2024 13F filing, EMERALD ADVISERS, LLC disclosed 247 equity positions with a combined reported value of $2.38B. The filing implies a diversified portfolio: its ten largest positions account for 21.3% of reported value. HoldingsHub classifies the profile as Mid / Diversified / High Turnover.

The largest disclosed positions as of Q2 2024 were FTAI ($85.65M), FRPT ($69.57M), CRS ($56.02M). By sector, the heaviest allocations are Technology 20.6%, Health Care 18.6%. Versus the prior quarter, allocation shifted toward Industrials (+2.8pp), Other (+0.6pp) and away from Consumer Discretionary (-0.5pp), Technology (-1.2pp).

Versus the prior quarter, EMERALD ADVISERS, LLC opened 14 new positions, trimmed 86 and fully exited 28, a turnover rate of 51.0% of positions. The portfolio's overlap with the prior quarter was 78% of names.

The largest new positions opened in Q2 2024 were MOD ($26.06M), VITL ($15.98M), XPRO ($13.42M).

Of the 28 positions fully exited versus the prior quarter, the largest were TMCI ($20.38M), DCPH ($16.44M), HRI ($13.73M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2024)

  • MOD MODINE MFG CO · $26.06M
  • VITL VITAL FARMS INC · $15.98M
  • XPRO EXPRO LTD · $13.42M
  • SPXC SPX TECHNOLOGIES INC · $13.35M
  • WVE WAVE LIFE SCIENCES INC · $12.44M
  • FN FABRINET · $12.19M
  • ARLO ARLO TECHNOLOGIES INC · $11.53M
  • FULT FULTON FINL CORP PA · $7.08M

Fully Exited (vs previous quarter)

  • TMCI TREACE MED CONCEPTS INC · prev qtr: $20.38M
  • DCPH DECIPHERA PHARMACEUTICALS IN · prev qtr: $16.44M
  • HRI HERC HLDGS INC · prev qtr: $13.73M · history
  • EXPO EXPONENT INC · prev qtr: $13.47M
  • CYTK CYTOKINETICS INC · prev qtr: $6.42M
  • PRVA PRIVIA HEALTH GROUP INC · prev qtr: $6.29M
  • REPL REPLIMUNE GROUP INC · prev qtr: $4.02M
  • ZVIA ZEVIA PBC · prev qtr: $1.41M

Insider Transactions (Form 4)

Latest EMERALD ADVISERS, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Emerald Advisers is an SEC-registered 13F filer based in Leola, PA, United States. As of Q2 2026 it reported 237 US equity positions with a combined value of $4.25B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: LEOLA, PA, United States
  • SEC registration: 801-40263 (status: Approved), registered 1991-11-25
  • Regulatory AUM (Form ADV): $3.30B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Website: teamemerald.com

Portfolio Structure

  • 237 positions · $4.25B reported value (Q2 2026)
  • Top 10 holdings = 17.4% of reported value
  • Largest position: TVTX (TRAVERE THERAPEUTICS INC) at 2.1%
  • Average position size: $17.93M

Sector Tilt

  • Information Technology 26.5%
  • Health Care 21.7%
  • Consumer Discretionary 19.5%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 28 new, 76 added, 81 reduced, 39 exited
  • 52 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Technology 20.6%
Health Care 18.6%
Industrials 14.6%
Financials 9.9%
Energy 2.7%
Other 15.4%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 829.70K $85.65M 3.59%
3.59%
Reduce
2 537.66K $69.57M 2.92%
2.92%
Reduce
3 511.20K $56.02M 2.35%
2.35%
Reduce
4 323.35K $48.70M 2.04%
2.04%
Reduce
5 1.51M $48.13M 2.02%
2.02%
Add
6 954.60K $45.79M 1.92%
1.92%
Reduce
7 640.27K $42.90M 1.80%
1.80%
Add
8 647.93K $38.18M 1.60%
1.60%
Reduce
9 681.20K $37.34M 1.57%
1.57%
Reduce
10 341.20K $36.77M 1.54%
1.54%
Reduce
11 605.30K $36.52M 1.53%
1.53%
Reduce
12 197.46K $35.97M 1.51%
1.51%
Hold
13 822.86K $35.86M 1.50%
1.50%
Reduce
14 441.37K $35.82M 1.50%
1.50%
Reduce
15 640.39K $35.51M 1.49%
1.49%
Reduce
16 1.76M $35.30M 1.48%
1.48%
Reduce
17 485.01K $35.26M 1.48%
1.48%
Add
18 243.48K $35.14M 1.47%
1.47%
Reduce
19 548.41K $33.20M 1.39%
1.39%
Reduce
20 736.10K $32.80M 1.38%
1.38%
Add
21 875.58K $31.85M 1.34%
1.34%
Reduce
22 359.15K $30.87M 1.29%
1.29%
Reduce
23 868.75K $30.81M 1.29%
1.29%
Reduce
24 845.96K $30.61M 1.28%
1.28%
Add
25 270.42K $30.14M 1.26%
1.26%
Reduce
26 393.18K $28.84M 1.21%
1.21%
Reduce
27 125.42K $27.54M 1.16%
1.16%
Reduce
28 96.76K $27.11M 1.14%
1.14%
Reduce
29 392.59K $26.89M 1.13%
1.13%
Reduce
30 168.60K $26.43M 1.11%
1.11%
Add
31 260.15K $26.06M 1.09%
1.09%
New
32 270.02K $25.71M 1.08%
1.08%
Add
33 1.84M $25.58M 1.07%
1.07%
Reduce
34 488.58K $25.38M 1.06%
1.06%
Add
35 271.95K $25.28M 1.06%
1.06%
Reduce
36 442.09K $25.27M 1.06%
1.06%
Reduce
37 240.34K $25.03M 1.05%
1.05%
Reduce
38 250.17K $25.02M 1.05%
1.05%
Reduce
39 434.49K $24.70M 1.04%
1.04%
Reduce
40 289.70K $23.85M 1.00%
1.00%
Add
41 394.96K $23.21M 0.97%
0.97%
Add
42 1.34M $22.69M 0.95%
0.95%
Reduce
43 443.00K $21.79M 0.91%
0.91%
Add
44 219.40K $21.54M 0.90%
0.90%
Add
45 567.00K $21.08M 0.88%
0.88%
Add
46 650.17K $20.94M 0.88%
0.88%
Reduce
47 486.68K $20.00M 0.84%
0.84%
Hold
48 565.21K $19.61M 0.82%
0.82%
Reduce
49 136.31K $19.03M 0.80%
0.80%
Reduce
50 254.88K $18.99M 0.80%
0.80%
Add

FAQ

What did EMERALD ADVISERS, LLC buy in 2024-Q2?

In its 2024-Q2 13F filing, EMERALD ADVISERS, LLC reported 247 equity positions worth $2.38B in aggregate; its largest disclosed positions were FTAI ($85.65M), FRPT ($69.57M), CRS ($56.02M).

How large is EMERALD ADVISERS, LLC's portfolio?

EMERALD ADVISERS, LLC reported $2.38B of long equity holdings across 247 positions as of 2024-Q2. Top-10 holdings account for 21.3% of reported value.

What is EMERALD ADVISERS, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Diversified / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/emerald-advisers/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →